Regnum Corp.
RGMP
Rank in Stocks
#34934
Regnum Corp. is dedicated to advancing and marketing therapeutic agents... Regnum Corp. is dedicated to advancing and marketing therapeutic agents designed to combat both rare and infectious diseases. Its flagship product is Leronlimab (PRO 140), a monoclonal antibody functioning as a C-C chemokine receptor type 5 (CCR5) antagonist. This drug is specifically formulated to inhibit the human immunodeficiency virus (HIV) from gaining entry into human cells. Headquartered in New York, New York, Regnum Corp. operates as a subsidiary of Phoenixus AG.
Share Price
$0.0001
Last synced: 2026-11-06
Market Cap
$2.30K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Regnum Corp. (RGMP)
Category
Healthcare
Operating Margin for Regnum Corp. (RGMP)
Operating Margin as of November 2026 TTM: 0.00%
According to Regnum Corp.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2022 the company had an operating margin of 0.00%.
Operating Margin history for Regnum Corp. from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -1,307.48% | 131.51% |
| 2019 | -564.76% | -3,607.83% |
| 2018 | 16.10% | 29.53% |
| 2017 | 12.43% | 0.00% |
| 2016 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Regnum Corp.'s operating margin
What was Regnum Corp.'s operating margin in 2022?
In 2022, Regnum Corp.'s operating margin was 0.00%, compared with 0.00% in 2021.
How has Regnum Corp.'s operating margin changed since 2017?
From 2017 to 2022, Regnum Corp.'s operating margin was highest in 2018 (16.10%) and lowest in 2020 (-1,307.48%).
How does Regnum Corp.'s operating margin compare with similar companies?
Regnum Corp.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.